Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytesMary Kelley(American University), Kathleen DeCicco-Skinner(American University)PLoS ONEMarch 24, 202210.1371/journal.pone.0266017Cited by 1SaveCiteExport RISWatch citationsRelated PapersInhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer|Oncogenesis|2019|33Unlocking Drug Resistance in Multiple Myeloma: Adipocytes as Modulators of Treatment Response|Cancers|2023|8Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in Tpl2−/− Mice|Cancers|2025|0